CTSO
Price:
$0.8705
Market Cap:
$47.38M
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and...[Read more]
Industry
Medical - Devices
IPO Date
2006-08-08
Stock Exchange
NASDAQ
Ticker
CTSO
According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -1.67. This represents a change of -24.22% compared to the average of -2.20 of the last 4 quarters.
The mean historical PE Ratio of Cytosorbents Corporation over the last ten years is -13.68. The current -1.67 PE Ratio has changed 1.12% with respect to the historical average. Over the past ten years (40 quarters), CTSO's PE Ratio was at its highest in in the June 2015 quarter at 26.51. The PE Ratio was at its lowest in in the December 2020 quarter at -122.28.
Average
-13.68
Median
-13.02
Minimum
-39.48
Maximum
-1.74
Discovering the peaks and valleys of Cytosorbents Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 512.47%
Maximum Annual PE Ratio = -1.74
Minimum Annual Increase = -81.26%
Minimum Annual PE Ratio = -39.48
Year | PE Ratio | Change |
---|---|---|
2023 | -1.74 | -15.52% |
2022 | -2.06 | -72.18% |
2021 | -7.40 | -81.26% |
2020 | -39.48 | 512.47% |
2019 | -6.45 | -55.30% |
2018 | -14.42 | -32.02% |
2017 | -21.21 | 82.72% |
2016 | -11.61 | -31.89% |
2015 | -17.05 | 11.02% |
2014 | -15.35 | 143.44% |
The current PE Ratio of Cytosorbents Corporation (CTSO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.73
5-year avg
-11.42
10-year avg
-13.68
Cytosorbents Corporation’s PE Ratio is less than ProSomnus, Inc. Common Stock (-0.59), less than LivaNova PLC (112.37), less than Electromed, Inc. (38.03), greater than OrthoPediatrics Corp. (-26.48), greater than Surmodics, Inc. (-380.53), greater than NeuroPace, Inc. (-6.15), greater than ClearPoint Neuro, Inc. (-19.46), less than TELA Bio, Inc. (-1.67), greater than CVRx, Inc. (-5.63), greater than Orthofix Medical Inc. (-5.47), greater than Artivion, Inc. (-136.92), greater than Heska Corporation (-91.49), greater than Paragon 28, Inc. (-8.85), greater than Inogen, Inc. (-2.31), greater than Pulmonx Corporation (-4.90), less than Apyx Medical Corporation (-1.42),
Company | PE Ratio | Market cap |
---|---|---|
-0.59 | $8.18M | |
112.37 | $2.66B | |
38.03 | $191.38M | |
-26.48 | $695.92M | |
-380.53 | $536.01M | |
-6.15 | $185.98M | |
-19.46 | $351.57M | |
-1.67 | $104.63M | |
-5.63 | $327.87M | |
-5.47 | $661.57M | |
-136.92 | $1.15B | |
-91.49 | $1.31B | |
-8.85 | $506.27M | |
-2.31 | $214.18M | |
-4.90 | $278.77M | |
-1.42 | $40.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cytosorbents Corporation's PE Ratio?
How is the PE Ratio calculated for Cytosorbents Corporation (CTSO)?
What is the highest PE Ratio for Cytosorbents Corporation (CTSO)?
What is the 3-year average PE Ratio for Cytosorbents Corporation (CTSO)?
What is the 5-year average PE Ratio for Cytosorbents Corporation (CTSO)?
How does the current PE Ratio for Cytosorbents Corporation (CTSO) compare to its historical average?